Label Changes for:
Caduet (amlodipine besylate/atorvastatin calcium) tablets
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- July 2009
The Atorvastatin Component of CADUET/Postintroduction Reports with Atorvastatin
- hepatic failure